+Search query
-Structure paper
Title | Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®. |
---|---|
Journal, issue, pages | Bioorg. Med. Chem. Lett., Vol. 29, Page 2428-2436, Year 2019 |
Publish date | Feb 14, 2019 (structure data deposition date) |
Authors | Taylor, J.G. / Zipfel, S. / Ramey, K. / Vivian, R. / Schrier, A. / Karki, K.K. / Katana, A. / Kato, D. / Kobayashi, T. / Martinez, R. ...Taylor, J.G. / Zipfel, S. / Ramey, K. / Vivian, R. / Schrier, A. / Karki, K.K. / Katana, A. / Kato, D. / Kobayashi, T. / Martinez, R. / Sangi, M. / Siegel, D. / Tran, C.V. / Yang, Z.Y. / Zablocki, J. / Yang, C.Y. / Wang, Y. / Wang, K. / Chan, K. / Barauskas, O. / Cheng, G. / Jin, D. / Schultz, B.E. / Appleby, T. / Villasenor, A.G. / Link, J.O. |
External links | Bioorg. Med. Chem. Lett. / PubMed:31133531 |
Methods | X-ray diffraction |
Resolution | 1.4 - 1.55 Å |
Structure data | PDB-6nzt: PDB-6nzv: |
Chemicals | ChemComp-L9P: ChemComp-ZN: ChemComp-SO4: ChemComp-HOH: ChemComp-L9J: |
Source |
|
Keywords | viral protein/inhibitor / viral protease inhibitor / voxilaprevir / hepatitis C virus / VIRAL PROTEIN / viral protein-inhibitor complex |